Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Graceway_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2006
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:fate |
acquired
|
| gptkbp:headquartersLocation |
gptkb:Saint_Paul,_Minnesota,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Aldara
Imiquimod Minitran |
| gptkbp:parentCompany |
gptkb:3M
|
| gptkbp:products |
drug delivery systems
pharmaceutical drugs |
| gptkbp:status |
defunct
|
| gptkbp:bfsParent |
gptkb:3MG
gptkb:Flecainide gptkb:imiquimod |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
3M Pharmaceuticals
|